Publication | Closed Access

Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines

VaccinationVaccine DevelopmentConventional Yeast-derived VaccinesImmunologyHepatitis BHepatitisPre-s2 AntigensVaccine DesignPolyvalent VaccineMedicineVaccine Research